Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest

Completed · Phase 1/Phase 2

Conditions studied: Cardiac Arrest

In brief

The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculatory flow in post-cardiac arrest patients.

Key facts

Study ID

NCT00676585

Run by

Beth Israel Deaconess Medical Center

People needed

50

Starts

2007-10-01

Expected to finish

2014-04-01

Last updated by the study team

2017-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Greater than 18 years old
• Either pre-hospital cardiac arrest and ROSC or Inpatient Cardiac Arrest with resultant ROSC
• Vasopressor dependent for a minimum of 1 hour post-arrest

You may not qualify if…

• Pregnant
• Indication for Corticosteroids outside of current research proposal
• DNR or comfort care measures
• Presence of septic shock
• Chronic Use (>1week) of oral Corticosteroids in the last year

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.